MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 48 filers reported holding MERSANA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3 | -62.5% | 2,500 | 0.0% | 0.00% | – |
| Q2 2023 | $8 | -73.3% | 2,500 | -66.7% | 0.00% | – |
| Q1 2023 | $30 | +114.3% | 7,500 | +200.0% | 0.00% | – |
| Q4 2022 | $14 | -99.9% | 2,500 | 0.0% | 0.00% | – |
| Q3 2022 | $16,000 | +45.5% | 2,500 | 0.0% | 0.00% | – |
| Q2 2022 | $11,000 | +22.2% | 2,500 | 0.0% | 0.00% | – |
| Q1 2022 | $9,000 | -40.0% | 2,500 | 0.0% | 0.00% | – |
| Q4 2021 | $15,000 | -99.3% | 2,500 | -98.4% | 0.00% | -100.0% |
| Q2 2021 | $2,087,000 | -16.1% | 153,742 | 0.0% | 0.01% | -11.1% |
| Q1 2021 | $2,487,000 | -39.9% | 153,742 | -1.2% | 0.01% | -43.8% |
| Q4 2020 | $4,138,000 | +395.0% | 155,542 | +246.2% | 0.02% | +300.0% |
| Q3 2020 | $836,000 | +206.2% | 44,931 | +284.0% | 0.00% | +300.0% |
| Q2 2020 | $273,000 | – | 11,700 | – | 0.00% | – |
| Q3 2018 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q2 2018 | $123,000 | +13.9% | 6,900 | 0.0% | 0.00% | – |
| Q1 2018 | $108,000 | +350.0% | 6,900 | +360.0% | 0.00% | – |
| Q4 2017 | $24,000 | -4.0% | 1,500 | 0.0% | 0.00% | – |
| Q3 2017 | $25,000 | – | 1,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $40,026,000 | 4.69% |
| Opaleye Management Inc. | 1,047,000 | $4,837,000 | 2.18% |
| Sarissa Capital Management LP | 4,299,297 | $19,863,000 | 2.00% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $4,178,000 | 1.58% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 850,000 | $3,927,000 | 1.21% |
| Orbimed Advisors | 9,011,437 | $41,633,000 | 0.75% |
| Avoro Capital Advisors LLC | 7,550,000 | $34,881,000 | 0.69% |
| Rock Springs Capital Management LP | 4,075,958 | $18,831,000 | 0.55% |
| Artal Group S.A. | 2,200,000 | $10,164,000 | 0.54% |
| DAFNA Capital Management LLC | 406,763 | $1,879,000 | 0.51% |